Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

 

In China, For China: AstraZeneca Invests $100 Million in Life Science R&D

Filed in archive Corporate and Industrial News by ruth on May 29, 2006

In China, For China: AstraZeneca Invests $100 Million in Life Science R&D
AstraZeneca just pledged to invest $100 million in research and development in China. The funds will be primarily used to build the AstraZenecalinks Innovation Centre China, which, according to the firm's press release, "will focus on translational science by developing knowledge about Chinese patients, biomarkers and genetics."
At the ICC, researchers will work on the identification, development, and validation of new biomarkers. Activities at the ICC will include analysis of human biological samples from clinical and experimental settings. The ICC will feature state-of-the-art biomedical informatics capabilities and advanced IS/IT support. The Centre will employ pre-clinical scientists and physicians who will progress both early and later-stage drug research projects.
Cancer research will be prioritized, and scientific collaborations will be strengthened particularly with the Wuxi Pharmatech for Compound Collection Synthesis and the Shanghai Jiaotong University on the genetics of schizophrenia.
"With China's rapid economic growth and increasing demand for better healthcare, China has become one of the most important emerging markets for AstraZeneca and will be important to our future success." said David Brennan, CEO of AstraZeneca PLC. "We fully support China's national focus on innovation by substantially increasing our R&D investment, both in financial terms and in terms of scientific collaboration."
Considering that China may very well be one of the largest pharmaceutical markets in the near future, this move displays vision, indeed. The company is now looking for a location appropriate for the Innovation Center, which they hope to be operational by late 2009.


Advertisement


Permalink: In China, For China: AstraZeneca Invests $100 Million in Life Science R&D
Tags: china  investment  biotech  life  science  million+life  invests+million  china+china 

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/23112



Advertisement


Advertisement


RSSrss   | See all blog subscribe options
Googlegoogle   |   What is RSS?
Yahoo!yahoo
AddthisAddThis Feed Button
BloglinesBloglines
Newsletter

Use our search feature to look for other interesting posts

Just this blog Whole network
 
  • Advertise with us

  • Learn more about our advertising options or email advertising - at - creative-weblogging.com or give Luis a call at +1 (650) 331 8047.


  • Testimonials

  • 'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

    'I subscribe to your blog and have been enjoying your posts and perspective.'
  • Other blogs in the same channel in the Creative Weblogging Network







 
Tagcloud: Biotech Hubs and Facilities Biotech/Science Blogs Corporate and Industrial News Diagnostics, Methodologies and Instrumentation Drugs, Vaccines and Therapeutics Energy, Environment and Ecology Food and Agriculture Gene Therapy Genomics, Proteomics and Bioinformatics Meetings and Other Events Microbiology Nanomedicine Other Biotechnology News Patents and Intellectual Property Rights Sponsored Post Stem Cells